J. Fox

发表

Comparison of the novel quantitative ARMS assay and an enriched PCR–ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses

D. Gouma, J. Fox, G. Offerhaus, 2005, Journal of Clinical Pathology.

Conference Scene: 5th Anniversary Meeting of the European Research Network Pharmacogenetics/Pharmacogenomics

I. Cascorbi, A. Alfirevic, J. Fox, 2012 .

Amplification quantitative de l'acide nucleique

V. Emery, J. Fox, P. Griffiths, 1992 .

Research Highlights: Highlights from the latest research in cytochromes pharmacogenomics

H. Hong, Jian Wang, Troy B. Hawkins, 2013 .

Highlights from the latest research in cytochromes pharmacogenomics Combining genetic variations in CYP 2 C 9 and VKORC 1 with clinical factors for warfarin dosing determination improved clinical effectiveness

H. Hong, Jian Wang, Troy B. Hawkins, 2010 .

Amplification Refractory Mutation System Linear Extension: A Novel, Gel‐Free, Enzyme‐Linked Immunoassay Method for DNA Genotyping

S. Little, J. Fox, C. Newton, 1998, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system.

I. Talbot, S. Little, J. Fox, 1998, British Journal of Cancer.

Toward personalized medicine in the neuropsychiatric field.

Chi-Ming Lee, J. Fox, Erik H. F. Wong, 2011, International review of neurobiology.

The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA)

R. D. de Boer, P. van der Harst, N. Verweij, 2014, BMC Medical Genetics.

' s response to reviews Title : The Impact of Coronary Artery Disease Risk Loci on Ischemic Heart Failure Severity and Prognosis : Data from the COntrolled ROsuvastatin multiNAtional trial in heart failure ( CORONA )

D. J. Veldhuisen, P. Harst, N. Verweij, 2014 .

Accurate detection of low prevalence AKT1 E17K mutation in tissue or plasma from advanced cancer patients

A. Kohlmann, C. Corcoran, G. Schiavon, 2017, PloS one.

Further evidence to support the melanocytic origin of MDA-MB-435

G. Ellison, T. French, J. Fox, 2002, Molecular pathology : MP.

Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA)

J. McMurray, R. D. de Boer, P. van der Harst, 2015, European journal of heart failure.

K-ras point mutation detection in lung cancer: comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification.

T. Liloglou, J. Field, S. J. Clayton, 2000, Clinical chemistry.

ARMS allele-specific amplification-based detection of mutant p53 DNA and mRNA in tumors of the breast.

N. J. Gibson, D. Hodgson, C. Foy, 2001, Clinical chemistry.

Detection of k-ras mutations in nonsmall cell lung-carcinoma.

G. Ellison, J. Field, H. Kiaris, 1995, International journal of oncology.

Further evidence to support the melanocytic origin of MDA-MB-435

G. Ellison, T. French, J. Fox, 2002, Molecular pathology : MP.

PROVISION OF PROGNOSTIC INFORMATION IN IMMUNOCOMPROMISED PATIENTS BY ROUTINE APPLICATION OF THE POLYMERASE CHAIN REACTION FOR CYTOMEGALOVIRUS

D. Pillay, V. Emery, J. Fox, 1993, Transplantation.